Conmed (CNMD) EBT Margin (2010 - 2026)
Conmed posted quarterly EBT Margin of 5.79% for Q1 2026, up 340.0% year-on-year from 1.32% in Q1 2025, and down 26.14% on a QoQ basis from 7.84% in Q4 2025.
Conmed (CNMD) has 17 years of EBT Margin data on file, last reported at 5.79% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin rose 340.0% year-over-year to 5.79%; the trailing twelve-month figure through Mar 2026 stood at 5.97% (down 507.0% YoY), and the FY2025 full-year result was 5.17%, down 730.0% from the prior year.
- EBT Margin for Q1 2026 stood at 5.79%, down from 7.84% in the prior quarter.
- Across five years, EBT Margin topped out at 17.83% in Q3 2024 and bottomed at 33.72% in Q2 2022.
- The 5-year median for EBT Margin is 6.66% (2023), against an average of 4.49%.
- The widest annual swing landed in 2022, when EBT Margin sank 4011 bps; it then surged 3921 bps in 2023.
- A 5-year view of EBT Margin shows it stood at 4.2% in 2022, then surged by 396 bps to 12.44% in 2023, then climbed by 1 bps to 12.62% in 2024, then tumbled by 38 bps to 7.84% in 2025, then retreated by 26 bps to 5.79% in 2026.
- The last three EBT Margin figures came in at 5.79% (Q1 2026), 7.84% (Q4 2025), and 1.26% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 27.84% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 22.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.84% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.17% |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn | 5.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.79% |
| Dec 31, 2025 | 7.84% |
| Sep 30, 2025 | 1.26% |
| Jun 30, 2025 | 8.74% |
| Mar 31, 2025 | 2.39% |
| Dec 31, 2024 | 12.62% |
| Sep 30, 2024 | 17.83% |
| Jun 30, 2024 | 11.30% |
| Mar 31, 2024 | 8.14% |
| Dec 31, 2023 | 12.44% |
| Sep 30, 2023 | 6.66% |
| Jun 30, 2023 | 5.48% |
| Mar 31, 2023 | 0.83% |
| Dec 31, 2022 | -4.20% |
| Sep 30, 2022 | 5.71% |
| Jun 30, 2022 | -33.72% |
| Mar 31, 2022 | 7.20% |
| Dec 31, 2021 | 10.82% |
| Sep 30, 2021 | 7.01% |
| Jun 30, 2021 | 6.38% |
| Mar 31, 2021 | 4.18% |
| Dec 31, 2020 | 5.34% |
| Sep 30, 2020 | 7.29% |
| Jun 30, 2020 | -20.75% |
| Mar 31, 2020 | 1.63% |
| Dec 31, 2019 | 6.51% |
| Sep 30, 2019 | 4.04% |
| Jun 30, 2019 | 2.73% |
| Mar 31, 2019 | -0.90% |
| Dec 31, 2018 | 8.37% |
| Sep 30, 2018 | 3.12% |
| Jun 30, 2018 | 5.45% |
| Mar 31, 2018 | 6.17% |
| Dec 31, 2017 | 8.22% |
| Sep 30, 2017 | 4.56% |
| Jun 30, 2017 | 4.25% |
| Mar 31, 2017 | -3.54% |
| Dec 31, 2016 | 4.26% |
| Sep 30, 2016 | 5.40% |
| Jun 30, 2016 | 2.03% |
| Mar 31, 2016 | -1.78% |
| Dec 31, 2015 | 5.96% |
| Sep 30, 2015 | 7.88% |
| Jun 30, 2015 | 6.04% |
| Mar 31, 2015 | 5.34% |
| Dec 31, 2014 | 7.97% |
| Sep 30, 2014 | 0.52% |
| Jun 30, 2014 | 7.64% |
| Mar 31, 2014 | 8.71% |
| Dec 31, 2013 | 7.23% |
| Sep 30, 2013 | 4.14% |
| Jun 30, 2013 | 7.39% |
| Mar 31, 2013 | 7.61% |
| Dec 31, 2012 | 7.76% |
| Sep 30, 2012 | 7.02% |
| Jun 30, 2012 | 8.17% |
| Mar 31, 2012 | 8.02% |
| Dec 31, 2011 | -23.54% |
| Sep 30, 2011 | 7.60% |
| Jun 30, 2011 | 7.57% |
| Mar 31, 2011 | 7.83% |
| Dec 31, 2010 | 5.78% |
| Sep 30, 2010 | 7.20% |
| Jun 30, 2010 | 6.56% |